Skip to content

F15.182 ICD-10-CM Code: Other stimulant abuse with stimulant-induced sleep disorder

F15.182 maps to CMS-HCC V28 137. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · HCC coding software

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupF15.182

FY 2026 Apr update / Mental, Behavioral and Neurodevelopmental disorders (F01-F99) / Mental and behavioral disorders due to psychoactive substance use (F10-F19)

F15.182

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Other stimulant abuse with stimulant-induced sleep disorder

Sleep problems (insomnia, hypersomnia, or other sleep disturbances) directly caused by stimulant drug abuse.

Buddy the Bee presenting code insight

Buddy Insight

Stimulant-induced sleep disorder during abuse is one of the most common complications of stimulant use, as these drugs directly disrupt sleep architecture through dopaminergic and noradrenergic mechanisms.

CMS-HCC V28

HCC 137

Coefficient HCC 137: 0.424 (Community Non-Dual Aged (CNA))

CMS-HCC V24

Historical

Historical

Not used for CY2026 payment

ACA/HHS

HCC 082

Code-level coefficient reference

ESRD/PACE

HCC 55

Code-level coefficient reference

RXHCC

N/A

Not mapped

Inclusion Terms

Official

No inclusion terms are included in this display for F15.182. Check the code and parent instructions in the Code Book.

Excludes 2

Official
  • symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)Inherited from F01-F99, F15
  • cocaine-related disorders (F14.-)Inherited from F01-F99, F15

Includes

Official
  • disorders of psychological developmentInherited from F01-F99, F15
  • amphetamine-related disordersInherited from F01-F99, F15
  • caffeineInherited from F01-F99, F15

Excludes 1

Official
  • other stimulant dependence (F15.2-)Inherited from F15.1
  • other stimulant use, unspecified (F15.9-)Inherited from F15.1

Code First

Official

No Code First sequencing instructions are included in this display for F15.182. Check the code and parent instructions in the Code Book.

Use Additional

Official

No Use Additional Code instructions are included in this display for F15.182. Check the code and parent instructions in the Code Book.

Code Also

Official

No Code Also instructions are included in this display for F15.182. Check the code and parent instructions in the Code Book.

Buddy Documentation Tip

HCC Buddy guidance
Documented stimulant abuse pattern with substance identified when possible
Specific sleep disorder described (insomnia, hypersomnia, parasomnia, circadian rhythm disruption)
Temporal relationship between stimulant use and sleep disturbance onset
Documentation that sleep disorder is substance-induced rather than a primary sleep disorder

MEAT Support

HCC Buddy guidance
Documented stimulant abuse pattern with substance identified when possible
Specific sleep disorder described (insomnia, hypersomnia, parasomnia, circadian rhythm disruption)
Temporal relationship between stimulant use and sleep disturbance onset
Documentation that sleep disorder is substance-induced rather than a primary sleep disorder

Audit Caution

HCC Buddy guidance
Coding primary insomnia (G47.00) separately when it is actually caused by stimulant use
Not querying the provider about the relationship between stimulant use and sleep complaints
Overlooking hypersomnia during stimulant withdrawal as a stimulant-induced sleep disorder
Using the unspecified code (F15.19) when the specific induced disorder (sleep) is documented

Common Mistakes

HCC Buddy guidance
F15.282 — Stimulant dependence with sleep disorder; requires documented dependence
F15.982 — Stimulant use, unspecified with sleep disorder; use when use pattern is unspecified
G47.00 — Insomnia, unspecified; use for primary insomnia, not substance-induced
G47.10 — Hypersomnia, unspecified; use for primary hypersomnia, not substance-induced

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is F15.182 an HCC code?

Yes. F15.182 (Other stimulant abuse with stimulant-induced sleep disorder) maps to HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 0.424. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.

Coder answer: F15.182 is billable and maps to V28 HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code
F15.182
Description
Other stimulant abuse with stimulant-induced sleep disorder
HCC (V28)
HCC 137 — Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications
RAF reference coefficient
0.424
Billable
Yes
Payment year
2026

HCC Category Mapping

V28HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications
0.424
ESRDHCC 55, Substance Use Disorder/Moderate/Severe/Substance Use with Complications
Not separately weighted

These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.

Work F15.182 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →

MEAT review for F15.182

For F15.182, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Coder workflow notes

Get the V28 mapping + MEAT cheat sheet

One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

F15.182 is the ICD-10-CM diagnosis code for other stimulant abuse with stimulant-induced sleep disorder. Sleep problems (insomnia, hypersomnia, or other sleep disturbances) directly caused by stimulant drug abuse. F15.182 sits in the ICD-10-CM chapter for mental, behavioral and neurodevelopmental disorders (f01-f99), within the section covering mental and behavioral disorders due to psychoactive substance use (f10-f19).

Under the CMS-HCC V28 risk adjustment model, F15.182 maps to Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications (HCC 137) with a source-labeled community, non-dual, aged reference coefficient of 0.424. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.

Document the specific sleep disturbance (insomnia, excessive daytime sleepiness, etc.) when documented. For F15.182, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for F15.182 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • Document the specific sleep disturbance (insomnia, excessive daytime sleepiness, etc.) when documented
  • Note that stimulants commonly cause insomnia during use and hypersomnia during withdrawal

Clinical Significance

Stimulant-induced sleep disorder during abuse is one of the most common complications of stimulant use, as these drugs directly disrupt sleep architecture through dopaminergic and noradrenergic mechanisms. Insomnia during active use and hypersomnia during withdrawal are hallmark features. Documenting this complication accurately captures the full burden of the substance use disorder for risk adjustment.

Documentation Requirements

  • Documented stimulant abuse pattern with substance identified when possible
  • Specific sleep disorder described (insomnia, hypersomnia, parasomnia, circadian rhythm disruption)
  • Temporal relationship between stimulant use and sleep disturbance onset
  • Documentation that sleep disorder is substance-induced rather than a primary sleep disorder
  • Impact on functioning and any sleep-related treatment interventions

Commonly Confused Codes

  • F15.282: Stimulant dependence with sleep disorder; requires documented dependence
  • F15.982: Stimulant use, unspecified with sleep disorder; use when use pattern is unspecified
  • G47.00: Insomnia, unspecified; use for primary insomnia, not substance-induced
  • G47.10: Hypersomnia, unspecified; use for primary hypersomnia, not substance-induced
  • F14.182: Cocaine abuse with cocaine-induced sleep disorder; use when cocaine is specifically identified

Child Codes

Code Hierarchy

Also searched as

  • F15 182
  • F15182

For F15.182, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

F15.182 maps to CMS-HCC V28 category 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications. See the ICD-10 to HCC mapping hub for how the V28 crosswalk works. The mapping identifies a payment HCC category for F15.182. Review its source-labeled HCC coefficient above, check the RAF Calculator with complete member context for CMS-HCC V28 PY2026, and confirm the documentation the chart needs before the code is submitted. HCC Buddy shows no RAF score unless every required source and calculation check passes.

Work F15.182 in HCC Buddy

Open F15.182 in the Code Book for the full Index-to-Tabular path, MEAT checklist, and V28 HCC mapping, or in the Encoder to code from a keyword search. Pro includes 7 days to try everything, no card required.